Currently, there are various drugs available for treating IBD, including immunomodulators (such as thiopurines and methotrexate (MTX)), biologic agents (such as TNFi, anti-integrin, and anti-IL12/23), as well as more recent options including Janus-kinase inhibitors and SP1 modulators [91]. Here, SP1 is linked to inflammatory bowel disease.